Company Overview - Heartflow, Inc. is a leader in AI technology for coronary artery disease (CAD) [1] - The company is advancing coronary care by transforming CAD into a screenable, diagnosable, and manageable condition [3] - Heartflow One is the only complete, non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway [3] - The AI-driven platform includes Roadmap™ Analysis, FFRCT Analysis, and Plaque Analysis, supported by the ACC/AHA Chest Pain Guideline and backed by over 600 peer-reviewed publications [3] - Heartflow has assisted clinicians in managing over 400,000 patients worldwide [3] Upcoming Events - Members of Heartflow management will participate in a fireside chat at the Morgan Stanley 23 Annual Global Healthcare Conference on September 10, 2025, at 6:15 a.m. PT / 9:15 a.m. ET [1] - A live and archived version of the fireside chat will be available on the Investor Relations section of the Heartflow website [2]

MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its common stock at a public offering price of $19 per share, which includes 2,500,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. All of the shares of common stock were offered by ...

MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public offering of 19,166,667 shares of its common stock at a public offering price of $19 per share, which includes 2,500,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares. All of the shares of common stock were offered by ...

MOUNTAIN VIEW, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its upsized initial public offering of 16,666,667 shares of its common stock at a public offering price of $19.00 per share. All of the shares of common stock are being offered by Heartflow. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payabl ...

Core Insights - UnitedHealthcare has announced comprehensive coverage for Heartflow Plaque Analysis, marking a significant advancement in patient access to AI-driven technology for diagnosing and managing coronary artery disease (CAD) [1][2] - The coverage will be effective from October 1, 2025, specifically for patients with acute or stable chest pain and mild-to-moderate coronary artery narrowing [2] - Heartflow Plaque Analysis is the only FDA-cleared, AI-enabled, noninvasive plaque quantification tool, demonstrating a 95% agreement with the gold standard, IVUS [3] Coverage Details - The updated coverage includes all lines of business for UnitedHealthcare, such as Commercial, Medicare Advantage, and Community plans [1] - This decision aligns with guidelines from radiology benefit manager EviCore, enhancing the standard for cardiovascular care coverage [1][2] Clinical Impact - Management changes informed by Heartflow Plaque Analysis resulted in an average LDL cholesterol decrease of 18.7 mg/dL, which is associated with a 15% reduction in the risk of cardiac events [4] - The technology has been shown to change medical management in over half of patients beyond CCTA alone, improving clinical outcomes [3] Company Vision - Heartflow aims to transform CAD from a leading cause of death into a manageable condition, with CAD responsible for one heart attack every 40 seconds in the U.S. [5] - The company has been adopted by over 1,400 institutions globally, indicating a strong commercial presence and commitment to making advanced solutions widely available [5][6]